Breaking News Instant updates and real-time market news.

WMT

Walmart

$115.01 /

-0.88 (-0.76%)

11:58
01/17/20
01/17
11:58
01/17/20
11:58

Walmart names Meng Chee as incoming Chief Product Officer

Meng Chee has been named Walmart's (WMT) first executive vice president and chief product officer. This new role will focus on delivering outstanding customer experiences and leveraging today's technology to do it. Meng comes to Walmart from JPMorgan Chase (JPM) where he served as managing director, head of digital customer experience. His appointment is effective as of February 1. Reference Link

  • 21

    Jan

WMT Walmart
$115.01 /

-0.88 (-0.76%)

01/16/20 Morgan Stanley
Target's holiday report may have implications for Walmart, says Morgan Stanley
01/15/20 Stifel
Target holiday miss has limited read-through to Walmart and Costco, says Stifel
01/10/20 Cleveland Research
Cleveland Research lowers Walmart Q4 U.S. comp estimate
01/08/20 Gordon Haskett
Gordon Haskett shakes up 'Shades of Grey' portfolio with downgrades, upgrade

TODAY'S FREE FLY STORIES

Recommendations
Village Farms price target lowered to $10 from $16 at Roth Capital » 07:49
04/02/20
04/02
07:49
04/02/20
07:49
VFF

Village Farms

/

+

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Fortuna Silver Mines downgraded to Sector Perform from Outperform at Scotiabank » 07:49
04/02/20
04/02
07:49
04/02/20
07:49
FSM

Fortuna Silver Mines

$2.18 /

-0.125 (-5.43%)

Scotiabank analyst Trevor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Pan American Silver upgraded to Sector Perform from Underperform at Scotiabank » 07:49
04/02/20
04/02
07:49
04/02/20
07:49
PAAS

Pan American Silver

$14.58 /

+0.26 (+1.82%)

Scotiabank analyst Trevor…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Momenta does not anticipate any disruptions to clinical supply » 07:49
04/02/20
04/02
07:49
04/02/20
07:49
MNTA

Momenta

$24.59 /

-2.59 (-9.53%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Aspen Technology downgraded to Neutral at Baird » 07:49
04/02/20
04/02
07:49
04/02/20
07:49
AZPN

Aspen Technology

$89.63 /

-5.47 (-5.75%)

As reported previously,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Vir, Alnylam expand collaboration for COVID-19 treatment development » 07:48
04/02/20
04/02
07:48
04/02/20
07:48
VIR

Vir Biotechnology

$29.78 /

-4 (-11.84%)

, ALNY

Alnylam

$104.51 /

-4.34 (-3.99%)

Vir Biotechnology (VIR)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Momenta expects Phase 2 study of M254 to commence in 2021 » 07:48
04/02/20
04/02
07:48
04/02/20
07:48
MNTA

Momenta

$24.59 /

-2.59 (-9.53%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Momenta says most sites in Phase 1/2 study of M254 have suspended enrollment » 07:47
04/02/20
04/02
07:47
04/02/20
07:47
MNTA

Momenta

$24.59 /

-2.59 (-9.53%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Momenta temporarily suspends patient enrollment in Energy study » 07:46
04/02/20
04/02
07:46
04/02/20
07:46
MNTA

Momenta

$24.59 /

-2.59 (-9.53%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Dynatronics withdraws FY20 revenue outlook amid COVID-19 pandemic » 07:46
04/02/20
04/02
07:46
04/02/20
07:46
DYNT

Dynatronics

$1.30 /

+0.4363 (+50.52%)

"During this…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Momenta expects slower pace of enrollment in Unity study » 07:45
04/02/20
04/02
07:45
04/02/20
07:45
MNTA

Momenta

$24.59 /

-2.59 (-9.53%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
DS Smith upgraded to Buy from Hold at Jefferies » 07:45
04/02/20
04/02
07:45
04/02/20
07:45
DITHF

DS Smith

$0.00 /

+ (+0.00%)

Jefferies analyst Cole…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Upgrade
Earthstone Energy upgraded to Buy from Neutral at Roth Capital » 07:45
04/02/20
04/02
07:45
04/02/20
07:45
ESTE

Earthstone Energy

$1.55 /

-0.17 (-9.88%)

Roth Capital analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Momenta on track to report data from Vivacity-MG study in 3Q20 » 07:45
04/02/20
04/02
07:45
04/02/20
07:45
MNTA

Momenta

$24.59 /

-2.59 (-9.53%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
U.S. Challenger reported announced job cuts spiked 222,288 in March to 165,628 » 07:45
04/02/20
04/02
07:45
04/02/20
07:45

U.S. Challenger reported…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Earnings
Dynatronics sees Q3 revenue $13.6M-$13.9M, consensus $14.03M » 07:44
04/02/20
04/02
07:44
04/02/20
07:44
DYNT

Dynatronics

$1.30 /

+0.4363 (+50.52%)

The decrease in net sales…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Citi opens 'Negative Catalyst Watch' on Ceridian amid 'intense' headwinds » 07:44
04/02/20
04/02
07:44
04/02/20
07:44
CDAY

Ceridian

$45.96 /

-4.1 (-8.19%)

Citi analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Momenta suspends enrollment in certain ongoing clinical trials » 07:43
04/02/20
04/02
07:43
04/02/20
07:43
MNTA

Momenta

$24.59 /

-2.59 (-9.53%)

Momenta Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Nephros withdraws 2020 revenue guidance » 07:42
04/02/20
04/02
07:42
04/02/20
07:42
NEPH

Nephros

$6.25 /

-0.03 (-0.48%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Caleres provides business update, furloughs associates amid COVID-19 pandemic » 07:42
04/02/20
04/02
07:42
04/02/20
07:42
CAL

Caleres

$3.81 /

-1.36 (-26.31%)

, CROX

Crocs

$15.51 /

-1.48 (-8.71%)

Caleres (CAL) provided a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
McKesson price target lowered to $147 from $155 at Credit Suisse » 07:42
04/02/20
04/02
07:42
04/02/20
07:42
MCK

McKesson

$133.24 /

-3.01 (-2.21%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Onto Innovation downgraded to Neutral from Buy at DA Davidson » 07:42
04/02/20
04/02
07:42
04/02/20
07:42
ONTO

Onto Innovation

$28.49 /

-0.98 (-3.33%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Nephros expects Q1 revenue $2.6M, two est. $3.12M » 07:42
04/02/20
04/02
07:42
04/02/20
07:42
NEPH

Nephros

$6.25 /

-0.03 (-0.48%)

"In this…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Lam Research downgraded to Neutral from Buy at DA Davidson » 07:41
04/02/20
04/02
07:41
04/02/20
07:41
LRCX

Lam Research

$223.36 /

-16.81 (-7.00%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Stealth Biotherapeutics price target lowered to $3 from $7 at BMO Capital » 07:41
04/02/20
04/02
07:41
04/02/20
07:41
MITO

Stealth Biotherapeutics

$1.28 /

+0.015 (+1.19%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.